iifl-logo

Sudarshan Pharma Industries Ltd EGM

Add as a Preferred Source on Google
26
(0.00%)
Feb 20, 2026|12:09:00 PM

Sudarshan Pharma CORPORATE ACTIONS

20/02/2025calendar-icon
20/02/2026calendar-icon
PurposeAnnouncement DateMeeting Date
EGM17 Jul 202511 Aug 2025
Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of Extraordinary General Meeting to be held on 11/August/2025 at 1.00 p.m. IST through video conferencing / other audio visual means Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations And Disclosure REquirements) Regulations, 2015, we enclose herewith the summary of proceedings of Extraordinary General Meeting held on Monday, 11th August 2025 at 1.00 pm through video conferencing / other audio visual means. (As per BSE Announcement Dated on 11.08.2025) Please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12/08/2025)
EGM16 May 202512 Jun 2025
Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find enclosed the Notice of Extraordinary General Meeting to be held on 12/June/2025 at 3.00 pm IST through video conferencing / other audio visual means. Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 we enclose herewith the summary of the proceedings of the Extraordinary General Meeting of the Company held on 12th June 2025 at 3.00 p.m. through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12.06.2025) Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Scrutinizers Report on the business transacted at the Extraordinary General Meeting of the Company held on Thursday, 12th June 2025 through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on :14.06.2025)

Sudarshan Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.